Dyne Therapeutics, Inc. (DYN)
DYN Stock Price Chart
Explore Dyne Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DYN price movements and trends.
DYN Company Profile
Discover essential business fundamentals and corporate details for Dyne Therapeutics, Inc. (DYN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Sept 2020
Employees
192.00
Website
https://www.dyne-tx.comCEO
John G. Cox
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
DYN Financial Timeline
Browse a chronological timeline of Dyne Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.81.
Earnings released on 28 Jul 2025
EPS came in at -$0.97 surpassing the estimated -$0.99 by +2.02%.
Earnings released on 8 May 2025
EPS came in at -$1.05 falling short of the estimated -$0.88 by -19.32%.
Earnings released on 27 Feb 2025
EPS came in at -$0.88 surpassing the estimated -$0.92 by +4.35%.
Earnings released on 12 Nov 2024
EPS came in at -$0.96 falling short of the estimated -$0.71 by -35.21%.
Earnings released on 12 Aug 2024
EPS came in at -$0.70 surpassing the estimated -$0.72 by +2.78%.
Earnings released on 2 May 2024
EPS came in at -$0.81 matching the estimated -$0.81.
Earnings released on 5 Mar 2024
EPS came in at -$1.09 falling short of the estimated -$0.92 by -18.48%, while revenue for the quarter reached $3.79M .
Earnings released on 30 Oct 2023
EPS came in at -$0.99 falling short of the estimated -$0.86 by -15.12%.
Earnings released on 3 Aug 2023
EPS came in at -$1.08 falling short of the estimated -$0.81 by -33.33%.
Earnings released on 11 May 2023
EPS came in at -$0.78 falling short of the estimated -$0.77 by -1.30%.
Earnings released on 2 Mar 2023
EPS came in at -$0.74 surpassing the estimated -$0.84 by +11.90%.
Earnings released on 3 Nov 2022
EPS came in at -$0.80 surpassing the estimated -$0.95 by +15.79%.
Earnings released on 4 Aug 2022
EPS came in at -$1.01 falling short of the estimated -$0.79 by -27.85%.
Earnings released on 2 May 2022
EPS came in at -$0.69 surpassing the estimated -$0.88 by +21.59%.
Earnings released on 10 Mar 2022
EPS came in at -$1.00 falling short of the estimated -$0.99 by -1.01%.
Earnings released on 4 Nov 2021
EPS came in at -$0.83 falling short of the estimated -$0.65 by -27.69%.
Earnings released on 5 Aug 2021
EPS came in at -$0.58 falling short of the estimated -$0.55 by -5.45%.
Earnings released on 6 May 2021
EPS came in at -$0.50 surpassing the estimated -$0.60 by +16.67%.
Earnings released on 4 Mar 2021
EPS came in at -$0.64 falling short of the estimated -$0.38 by -68.42%.
Earnings released on 5 Nov 2020
EPS came in at -$2.01 falling short of the estimated -$0.87 by -131.03%.
Earnings released on 17 Sept 2020
EPS came in at -$0.62 .
DYN Stock Performance
Access detailed DYN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.